| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |